Election 2014

Paonta Sahib

Mar 23, 2014 at 15:39 | Source: PTI
"If they (the US) want a discussion in WTO (World Trade Organization), we are more than ready because we are not in any breach. We are very clear," Commerce and Industry Minister Anand Sharma told PTI.
Sep 22, 2013 at 11:58 | Source: PTI
Ranbaxy Laboratories, which was acquired by Japanese drug maker Daiichi Sankyo in 2008, commissioned the Mohali plant in 2011 and started exports from there in 2012. It is the third Ranbaxy facility in India to face FDA action, after the Dewas and Paonta Sahib plants.
Sep 17, 2013 at 15:14 | Source: CNBC-TV18
Nomura has a buy whereas Antique has a sell on Ranbaxy.
Sep 16, 2013 at 09:00 | Source: CNBC-TV18
Import alert issued by USFDA on Ranbaxy's Mohali plant could not only be negative for the stock but according to the analyst community Ranbaxy could be on its last legs for having a good strong base in the US.
Aug 30, 2013 at 16:20 | Source: CNBC-TV18
Sources indicate that the deficiencies noted during DCGI inspections are not serious enough to attract suspension charges
Jul 02, 2013 at 17:29 | Source: Moneycontrol.com
Drug maker Ranbaxy Labs rose 6.5 percent to close at Rs 345.25 after USFDA told CNBC-TV18 that there is no proof of data reliability issues other than at 3 units that are Paonta Sahib, Batamandi & Dewas.
Jun 25, 2013 at 12:12 | Source: IBNLive.com
The PIL was filed against Ranbaxy for allegedly manufacturing and selling of the adulterated drug. The petitioner cited the pharma giant's case in the US where Ranbaxy USA admitted to selling substandard and adulterated drugs.
Jun 24, 2013 at 15:16 | Source: Moneycontrol.com
The stock hit a near 4-year low after a news report said the US FDA may have issued a form 483 to its Mohali facility. The company has already pleaded guilty to felony charges related to manufacturing practises at its Dewas and Paonta Sahib plants.
Jun 05, 2013 at 09:54 | Source: IBNLive.com
The PIL is seeking prosecution of all Ranbaxy directors and sealing of its manufacturing units at Paonta Sahib and Devas.
May 22, 2013 at 20:09 | Source: CNBC-TV18
Diiachi says that certain former shareholders "misrepresented critical information".
Messages on Paonta Sahib »

R Jagannathan

Platinum Member


Ranbaxy Labs  

imports from all of its four plants – Paonta Sahib, Dewas, Mohali and Toansa. Ranbaxy is thus crippled in the US generics market despite an early lead. Under Daiichi it has slipped further. If six years after buying Ranbaxy for $4.2 billion Daiichi now exits at an enterprise value of $4 billion

11.06 AM Apr 9th


Platinum Member


Ranbaxy Labs  

In May last year, Ranbaxy pleaded guilty to `felony charges` related to the manufacture and distribution of certain `adulterated` drugs made at the Dewas and Paonta Sahib units and agreed to pay USD 500 million to US authorities as penalty.

10.06 PM Mar 14th


New Member


Ranbaxy Labs  

Usfda gives warning letter for paonta sahib ranbaxy and banned mohali plant sell guys tgt 340

1.22 PM Feb 19th


Platinum Member


Ranbaxy Labs  

..The Toansa facility, which supplies 70-75% of pharma ingredients, is Ranbaxy`s main API factory.All the other India-based Ranbaxy factories — at Paonta Sahib (Himachal Pradesh), Dewas (Madhya Pradesh) and Mohali (Punjab) — are already barred from exporting drugs to the US, the firm’s largest market

11.39 AM Jan 14th


Platinum Member


Business Talk  

in 2008, import alerts were triggered against shipments from two other plants owned by Ranbaxy — in Dewas, Madhya Pradesh, and Paonta Sahib, Himachal Pradesh — following which exports to the US were banned. In May this year, Ranbaxy pleaded guilty to felony charges related to drug safety and agreed

10.06 PM Dec 19th 2013


Silver Member



-blower`s lawsuit alleges the company defrauded Federal programmes Jun 2008: Daiichi Sankyo acquires majority stake in Ranbaxy Sep 2008: Ranbaxy`s three facilities - at Paonta Sahib and Batamandi (Himachal Pradesh) and Dewas (in Madhya Pradesh) - come under FDA`s scanner. FDA bans 30 drugs from Indian facilities

6.11 PM Nov 27th 2013


Gold Member


Ranbaxy Labs  

Dear ROG!! Jigs`s latest call included Ranbaxy for accumulation. I think the risks associated with USFDA alert was already there when the call was given. The basic premises of jigs` call was that the prevailing price already accounted for the USFDA alert for its plants in Paonta Sahib / Mohali

11.49 PM Oct 2nd 2013


Platinum Member


Ranbaxy Labs  

.S. shipments from its plants at Dewas and Paonta Sahib. Ranbaxy has said the implementation of a consent decree it signed in January 2012 with the FDA to restart shipments has "progressed as per plan". While Ranbaxy shares have recovered, the case put a cloud over the industry. "We all know how

11.42 AM Sep 15th 2013


Platinum Member



.98 % to explain the deficiencies its special inspection team found at the company`s Dewas and Paonta Sahib plants. A Ranbaxy spokesperson refused to comment on the issue. "Even in case of Ranbaxy, the inspection team did not find any major deviation from domestic drug laws at Dewas or Paonta Sahib facilities

2.31 PM Sep 2nd 2013


Platinum Member



1-2km from dakpathar close to "paonta sahib" .. the only problem being the constant outage.. even though UK is supposed to be a power surplus state.. most of the power was committed for export .. rather than local consumption.. resulting in power cuts.. its really stupid.. sitting close to a hydro

10.38 AM Sep 2nd 2013

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.